Elitek
Term · Oncology and biomedicine · MLC-T-ONC-002749
A drug used to treat high levels of uric acid in the blood of adults and children with leukemia, lymphoma, or other types of cancer who are receiving certain types of anticancer therapy. Uric acid is a natural substance that can build up in the blood as tumors break down. Elitek helps break down and remove uric acid from the body. It is a type of recombinant enzyme and a type of urate-lowering drug. Also called rasburicase and recombinant urate oxidase.
| Identifier | MLC-T-ONC-002749 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | rasburicase; recombinant urate oxidase |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-002749",
"term": "Elitek",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat high levels of uric acid in the blood of adults and children with leukemia, lymphoma, or other types of cancer who are receiving certain types of anticancer therapy. Uric acid is a natural substance that can build up in the blood as tumors break down. Elitek helps break down and remove uric acid from the body. It is a type of recombinant enzyme and a type of urate-lowering drug. Also called rasburicase and recombinant urate oxidase.",
"synonyms": [
"rasburicase",
"recombinant urate oxidase"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/elitek/"
}
Record 6,547 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.